Oncoinvent is a drug development company based in Oslo, Norway. Oncoinvent develops novel alpha-emitting radioactive cancer treatments. Oncoinvents lead product Radspherin is currently undergoing clinical testing for the treatment of peritoneal carcinomatosis, a common metastatic complication of colorectal and ovarian cancer.
![logo_lrg-1](https://hadeanventures.com/wp-content/uploads/2020/06/logo_lrg-1-300x163.png)
YEAR OF INVESTMENT
2020
SECTOR
Drug development
LOCATION
Oslo, Norway
WEBSITE
https://www.oncoinvent.com/